Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Comparing ETFs and mutual funds for retirement reveals tax efficiency differences driven by turnover, distributions, and account placement.
28,114 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Federal regulators weigh possible actions after new allegations that polymarket allegedly faked trades. The case test...
Dram stocks surged on AI-driven demand, yet the rally carries volatility and a stubborn supply gap. This analysis exp...
As July 18, 2026 approaches, the GENIUS Act deadline accelerates rulemaking for stablecoin issuers. Regulators from T...
June retail sales rose modestly, led by auto purchases and a surge in online spending during Prime Day-like promotion...
Chemours faces a year of nuanced cycles in pigments and fluorochemicals. This guide breaks down what to watch in chem...
Robotics stocks soar tuesday as OUST and TER led a broad move higher on AI demand and automation optimism. Strong Q4 ...
Bitcoin and Ethereum lead a broad crypto rebound as on-chain data shows heavy whale buying. XRP and major altcoins ra...
Markets are rotating away from AI hype toward real, tangible assets. A small engineering firm is asserting itself wit...
NextEra Energy is pursuing a $67 billion all-stock deal to buy Dominion, aiming to create the world’s largest utility...
Fomo has closed a $75 million Series B round led by Index Ventures, pushing the company’s valuation to $550 million a...
Steve Madden Ltd. will not provide earnings guidance for the upcoming quarter after a Supreme Court tariff ruling inj...